N-acetylcysteine and acute lung injury;Utilisation therapeutique de la N-acetylcysteine au cours des agressions pulmonaires aigues

Revue des Maladies Respiratoires

Volumn 16, Issue 1, 1999, Pages 29-37

  Domenighetti, G ^a   Quattropani, C ^a   Schaller, M D ^b  

^a Serv Soins Intensifs M   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Acute lung injury; Antioxidants; N acetylcysteine; Oxidants

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ARTICLE; DRUG MECHANISM; LUNG FUNCTION; LUNG INJURY; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; RESPIRATORY DISTRESS; ACUTE DISEASE; HUMAN; LUNG DISEASE; METABOLISM; REVIEW;

ACETYLCYSTEINE; ACUTE DISEASE; FREE RADICAL SCAVENGERS; HUMANS; LUNG DISEASES; REACTIVE OXYGEN SPECIES;

EID: 0033071768     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. HALLIWELL B: Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 1991;91(suppl. 3C):14S-22S.
2. SCHRAUFSTAETTER IU, COCHRANE CG : Oxydants : types, sources and mechanism of injury. In : Crystal RG, West JB, eds. The Lung. New York : Raven Press 1991:1803-10.
3. HEFFNER JE, REPINE JE : Pulmonary strategies of antioxydant defense. Am Rev Respir Dis 1989;140:531-54.
4. BAST A, HAENEN RM, DOELMAN CJ : Oxydants and antioxydants : state of the art. Am J Med 1991;91(suppl 3C):2S-13S.
5. RUFFMANN R, WENDEL A : GSH rescue by N-Acetylcysteine. Klin Wochenschr 1991;69:857-62.
6. HEFFNER JE, REPINE JE : Antioxydants and the lung. In : Crystal RG, West JB, eds. The Lung. New York : Raven Press 1991:1811-20.
7. FLANAGAN RJ, MEREDITH TJ : Use of N-Acetylcysteine in Clinical Toxicology. Am J Med 1991;91(suppl. 3C):131S-38S.
8. SOERNSTRAND B : Is N-Acetylcysteine a free radical scavenger in vivo ? The effect of N-acetylcysteine in oxygen-induced lung injury. Eur Respir Rev 1992;2:7,11-5.
9. MOLDEUS P, COTGREAVE IA, BERGGREN M : Lung protection by a thiol-containing antioxydant : N-acetylcysteine. Respiration 1986;50:31-42.
10. RODENSTEIN D, DE COSTER A, GAZZANIGA A : Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders. Eur J Respir Dis 1980;61(suppl. 111):59-60.
11. HARRISON PM, WENDON JA, GIMSON AE, ALEXANDER GJ: Improvement by acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-7.
12. SPIESS CL, REINHART K, WITT I, MEIER-HELLMANN A, HANNEMANN L, BREDLE DL, SCHAFFARTZIK W : Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic schock patients : results from a prospective, randomized, double-blind study. Crit Care Med 1994;22:1738-46.
13. MONCADA S, PALMER R, HIGGS E : Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109-42.
14. LUNDBAECK S, LINSTROEM M, ANDERSSON S, NYSTROEM L, ROSENHALL L, STJERNBERG N : Possible effect of acetylcysteine on lung function. Eur Respir J 1995;5(suppl. 15): 289S-91S.
15. BERNARD GR, ARTIGAS A, BRIGHAM KL et al. : Report of the American-European Consensus Conference on ARDS : Definitions, mechanism, relevant outcomes and clinical trial coordination. Intensive Care Med 1994;20:225-32.
16. BRIGHAM KL : Oxydant stress and adult respiratory distress syndrome. Eur Respir J 1990;3(suppl. 11):482S-84S.
17. REPINE JE : Neutrophils, oxygen radicals and the adult respiratory distress syndrome. In : Said S, ed. The pulmonary circulation and the acute lung injury. New York : Futura Publishing Co 1985:149-81.
18. TATE RM, VANBENTHUYSEN KM, SHASBY DM, MCMURTRY IF, REPINE JE : Oxygen-radical mediated permeability edema and vasoconstriction in isolated perfused rabbit lung. Am Rev Respir Dis 1982;126:802-6.
19. REPINE JE, PARSONS PE: Oxydant-antioxydant balance in endotoxin-induced oxydative injury and tolerance to oxydative injury. In : Brighham KL, ed. Endotoxin and the lung. New York: Marcel Dekker, 1994;207-27.
20. BUNNEL E, PACHT ER : Oxydized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1174-8.
21. TAGAN MC, MARKERT M, SCHALLER MD, FEIHL F, CHIOLERO R, PERRET CL : Oxydative metabolism of circulating granulocytes in adult respiratory distress syndrome. Am J Med 1991;91(suppl. 3C):72S-78S.
22. BERNARD GR, LUCHT WD, NIEDEMEYER ME, SNAPPER JR, OCLETREE ML, BRIGHAM KL : Effect of N-Acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in-vitro granulocyte function. J Clin Invest 1984;73:1772-84.
23. BERNARD GR, SWINDELL DB, MEREDITH MJ, CARROLL FE, HIGGINS SB : Gluthathione repletion by N-Acetylcysteine in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1989;739:A221.
24. LAURENT TH, MARKERT M, FEIHL F, SCHALLER MD, PERRET CL : Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest 1996;109:163-6.
25. JEPSEN S, HERLEVSEN P, KNUDSEN P, BUD M, KLAUSEN NO : Antioxidant treatment with N-Acetylcysteine during adult respiratory distress syndrome : a prospective, randomized, placebo-controlled study. Crit Care Med 1992;20:918-23.
26. SUTER PM, DOMENIGHETTI G, SCHALLER MD, LAVERRIERE MC, RITZ R, PERRET CL : N-Acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994;105:190-4.
27. DE BACKER WA, AMSEL B, JORENS PG et al. : N-Acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Med 1996;22:900-8.
28. BERNARD GR, WHEELER AD, ARONS MM et al : The Antioxydant in ARDS Study Group. A trial of antioxydants N-Acetycysteine and Procysteine in ARDS. Chest 1997;112:164-72.
29. DOMENIGHETTI G, SUTER PM, SCHALLER MD, RITZ R, PERRET CL : Treatment with N-Acetylcysteine (NAC) during acute respiratory distress syndrome. A randomized, double-blind, placebo-controlled clinical study. J Crit Care 1997;12:177-82.
30. REINHART K, SPIESS CL, MEIER-HELLMANN A et al. : N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. Am J Respir Crit Care Med 1995;151:773-9.
31. GOODE HF, WEBSTER NR : Free radicals and antioxydants in sepsis. Crit Care Med 1993;21:1770-6.
32. GASTON B, RILEY J, DRAZEN J : Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993;90:957-61.
33. ZHANG H, SPAPEN H, NGUYEN DN, BENLABED M, BUURMAN WA, VINCENT JL : Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994;266:H1746-H54.
34. SCHMIDT H, SCHMIDT W, MUELLER TH, BOEHRER H, GEBHARD MM, MARTIN E : N-acetylcysteine attenuates endotoxin-induced leucocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997;25:858-63.
35. PEAKE SL, MORAN JL, LEPPERD PI : N-acetylcysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996;24:1302-10.
36. STAMLER J, MENDELSOHN ME, AMARANTE P : N-Acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-95.
37. DAVIS BW, RENNARD SI, BITTERMANN PS, CRYSTAL RG : Pulmonary oxygen toxicity. N Engl J Med 1983;309:878-83.
38. LODATO R : Decreased oxygen consumption and cardiac output during normobaric hyperoxia in conscious dogs. J Appl Physiol 1989;67.1551-9.
39. RUBANYI GM, VANHOUTTE PM : Superoxyde anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H27.
40. 2 toxicily by N-acetylcysteine. Eur Respir J 1989;2:116-26
41. REINHART K, BLOOS F, KOENIG D, BREDLE A, HANNEMANN L : Reversible decrease of oxygen consumption by hyperoxia. Chest 1991;99:690-4.
42. PEDRAZZINI GB, SAGLINI V, PEDRINIS E, MOMBELLI G, DOMENIGHETTI G : Intoxication volontaire fatale au paraquat par voie parenterale. Schweiz Med Wschr 1991;121:1293-7.